A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, ...

Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...

Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But ...

Michael J. Fox might have a wholesome reputation these days, but he and a bunch of his celebrity friends once got busted by ...

Dogs for the Disabled, a charity started in Cork in 2007 with the aim of training specially bred dogs to assist disabled children and adults to live independent lives, was approached by a former ...

Yet that’s not to say that in his advanced age, Ozzy’s had it easy in the health department. Nagging physical ailments, in ...

(Mike Stocker/South Florida Sun Sentinel) Zucker said the hospital has a wait list of about a year for patients with essential tremor or tremor-dominant Parkinson’s to be treated with focused ...

It’s not a secret that sleep can get more difficult with age — research suggests that up to half of older adults complain of ...

Rhaeos moved into Fulton Labs in January, effectively moving its headquarters from Evanston to Chicago. The company employs 17 people, most of whom work out of the Fulton Labs office — the others are ...

Zucker said the hospital has a wait list of about a year for patients with essential tremor or tremor-dominant Parkinson’s to ... think we have some infusion drugs, we have focused ultrasound ...